At EuroPCR 2018, two new studies involving the HeartFlow FFRCT Analysis were presented: PACIFIC Sub-Study and SYNTAX III Revolution. The studies reinforce the value of the HeartFlow Analysis in providing functional evaluation of coronary blockages and enabling clinicians to make treatment decisions. Hear from Gregg Stone, MD, Campbell Rogers, MD, Paul Knaapen, MD, PhD, and Patrick Serruys, MD, PhD, as they discuss the results and explore what these findings mean for the non-invasive cardiology field.
![](https://i.ytimg.com/vi/rXR8hsqGKBQ/maxresdefault.jpg)